TimeScale Financial’s Edwards Lifesciences EW Stock Holding History

TimeScale Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$58.9K	Hold	624	–	–	0.01%	199
2023 Q1	$51.6K	Hold	624	–	–	0.01%	206
2022 Q4	$51.6K	Hold	624	–	–	0.02%	158
2022 Q3	$52K	Hold	624	–	–	0.02%	156
2022 Q2	$59K	Hold	624	–	–	0.02%	145
2022 Q1	$73K	Hold	624	–	–	0.02%	145
2021 Q4	$81K	Hold	624	–	–	0.02%	143
2021 Q3	$71K	Hold	624	–	–	0.02%	150
2021 Q2	$65K	Hold	624	–	–	0.02%	157
2021 Q1	$52K	Hold	624	–	–	0.01%	174
2020 Q4	$57K	Hold	624	–	–	0.02%	151
2020 Q3	$49K	Hold	624	–	–	0.01%	155
2020 Q2	$43K	Hold	624	–	–	0.01%	160
2020 Q1	$39K	Sell	624 -429	-41%	-$30.9K	0.01%	152
2019 Q4	$81K	Hold	1,053	–	–	0.02%	132
2019 Q3	$77K	Buy	1,053 +429	+69%	+$30.1K	0.03%	136
2019 Q2	$38K	Buy	+624	New	+$37.7K	0.01%	211

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TimeScale Financial's EW Position: Q2 2023 in Review

TimeScale Financial held its Edwards Lifesciences (EW) position steady in Q2 2023 at 624 shares worth $58.9K. The position accounts for 0.01% of the portfolio, ranked #199.

TimeScale Financial first reported a position in EW in Q2 2019 and has held it in 17 quarters since. The position peaked at $81K in Q4 2021. 1,278 funds tracked by Wall St. Rank hold EW as of Q2 2023.

TimeScale Financial held 624 shares of Edwards Lifesciences worth $58.9K as of Q2 2023.
TimeScale Financial left its Edwards Lifesciences share count unchanged in Q2 2023.
Edwards Lifesciences made up 0.01% of TimeScale Financial's portfolio in Q2 2023, its #199 holding.
TimeScale Financial first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 17 quarters since.
TimeScale Financial's Edwards Lifesciences position peaked at $81K in Q4 2021.
1,278 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.